Immune Checkpoint Inhibition in Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma (HNSCC) is the 6th most common cancer globally and commonly presents with locally advanced disease, which has a recurrence rate of around 50% despite aggressive multi-modality treatment involving surgery, radiotherapy and chemotherapy or EGFR inhibition where ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Forster, Martin David, Devlin, Michael-John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123367/
https://www.ncbi.nlm.nih.gov/pubmed/30211111
http://dx.doi.org/10.3389/fonc.2018.00310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123367/
https://www.ncbi.nlm.nih.gov/pubmed/30211111
http://dx.doi.org/10.3389/fonc.2018.00310

Ejemplares similares